These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31540423)

  • 1. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway.
    Singh SK; Apata T; Gordetsky JB; Singh R
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.
    Dirican A; Atmaca H; Bozkurt E; Erten C; Karaca B; Uslu R
    Clin Transl Oncol; 2015 Feb; 17(2):145-51. PubMed ID: 25060568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
    Qian S; Zhang S; Wu Y; Ding Y; ; Li X
    Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
    Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
    Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
    Mathur A; Abd Elmageed ZY; Liu X; Kostochka ML; Zhang H; Abdel-Mageed AB; Mondal D
    PLoS One; 2014; 9(8):e103109. PubMed ID: 25121735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines.
    Karaca B; Degirmenci M; Ozveren A; Atmaca H; Bozkurt E; Karabulut B; Sanli UA; Uslu R
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1273-80. PubMed ID: 25925002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells.
    Alkhatib MH; Bawadud RS; Gashlan HM
    Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
    Singh SK; Lillard JW; Singh R
    Cancer Lett; 2018 Jul; 427():49-62. PubMed ID: 29678549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.
    Liu Z; Zhu G; Getzenberg RH; Veltri RW
    J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.
    Chao H; Wang L; Hao J; Ni J; Chang L; Graham PH; Kearsley JH; Li Y
    Cancer Lett; 2013 Feb; 329(1):17-26. PubMed ID: 22995071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect.
    Xu W; Ding J; Kuang S; Li B; Sun T; Zhu C; Liu J; Zhu L; Li Y; Sheng W
    Cancer Cell Int; 2023 Sep; 23(1):190. PubMed ID: 37660001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma.
    Deng L; Wu X; Zhu X; Yu Z; Liu Z; Wang J; Zheng Y
    Am J Transl Res; 2021; 13(1):57-72. PubMed ID: 33527008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone-induced reactive oxygen species causes apoptosis of chondrocytes via PI3K/Akt and p38kinase pathway.
    Yu SM; Kim SJ
    Exp Biol Med (Maywood); 2013 Jul; 238(7):811-20. PubMed ID: 23788172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
    Ren W; Joshi R; Mathew P
    Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer.
    Park H; Kim Y; Sul JW; Jeong IG; Yi HJ; Ahn JB; Kang JS; Yun J; Hwang JJ; Kim CS
    Prostate; 2015 Nov; 75(15):1747-59. PubMed ID: 26250606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
    Sekino Y; Oue N; Koike Y; Shigematsu Y; Sakamoto N; Sentani K; Teishima J; Shiota M; Matsubara A; Yasui W
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30744126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of Docetaxel-Induced Cytotoxicity in Human PC-3 Androgen-Independent Prostate Cancer Cells by Combination With Four Natural Apoptosis-Inducing Anticancer Compounds.
    Ahmed IA; Hafiz S; van Ginkel S; Pondugula SR; Abdelhaffez AS; Sayyed HG; El-Aziz EAA; Mansour MM
    Nat Prod Commun; 2023 May; 18(5):. PubMed ID: 37292146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.